"We know facing a cancer diagnosis can be frightening. But we want you to know that you will be in good hands with us, surrounded by a caring team of compassionate professionals who will be by your side and will hold your hand. We’ll be focused on you and your loved ones as long as you need us."

During the past decade, Compass Oncology Vancouver conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 38 clinical trials were completed, i.e. on average, 345.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 21 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Compass Oncology Vancouver" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Compass Oncology Vancouver" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Compass Oncology Vancouver" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Cancer" (3 trials), "Gliosarcoma" (3 trials) and "Adult Glioblastoma" (2 trials). Many other conditions were trialed in "Compass Oncology Vancouver" in a lesser frequency.

Most popular intervention types in "Compass Oncology Vancouver" are "Drug" (46 trials), "Other" (35 trials), "Biological" (19 trials), "Radiation" (15 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (8 trials), "Paclitaxel" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Compass Oncology Vancouver" are 44 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Compass Oncology Vancouver". undefined are not yet recruiting, 1 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Compass Oncology Vancouver, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Compass Oncology Vancouver, 4 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Compass Oncology Vancouver has several departments that took part in Clinical trials: "Northwest Cancer Specialists, P.C." - 88 trials, "Compass Oncology Rose Quarter" - 39 trials, "Northwest Cancer Specialists, P.C. 265 N Broadway" - 2 trials